{"nct_id":"NCT01017952","title":"A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","status_verified_date":"2018-08","start_date":"2009-09-25","start_date_type":null,"primary_completion_date":"2011-10-01","primary_completion_date_type":"ACTUAL","completion_date":"2011-10-17","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}